The Centre de recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR) of the CIUSSS de l'Est-de-l'Île-de-Montréal is a high-level research institute in cellular and molecular therapy and regenerative medicine. The CR-HMR is recognized for its 3 axes of excellence: immunology-oncology, nephrology and vision health. At the centre, 42 researchers, 134 students and 114 professionals work closely together to develop new therapies and solutions that provide hope for patients. Affiliated with Université de Montréal, the CR-HMR is recognized by the Fonds de recherche du Québec – Santé.